AB 552

This bill prohibits every health insurance policy and governmental

self-insured health plan that cover insulin and impose cost sharing on prescription

drugs from imposing cost sharing on insulin in an amount that exceeds $50 for a

one-month supply. Current law requires every health insurance policy that provides

coverage of expenses incurred for treatment of diabetes to provide coverage for

specified expenses and items, including insulin. The required coverage under

current law for certain diabetes treatments other than insulin infusion pumps is

subject to the same exclusions, limitations, deductibles, and coinsurance provisions

of the policy as other covered expenses. The bill's cost-sharing limitation on insulin

supersedes the specification that the exclusions, limitations, deductibles, and

coinsurance are the same as for other coverage.

This proposal may contain a health insurance mandate requiring a social and

financial impact report under s. 601.423, stats.